Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retrovirals

This publication has 9 references indexed in Scilit:

• R57K Polymorphism in the Human Immunodeficiency Virus Type 1 Protease as Predictor of Early Virological Failure in a Cohort of Antiretroviral-Naive Patients Treated Mostly with a Nelfinavir-Containing Regimen
  Antimicrobial Agents and Chemotherapy, 2003
• Role of Baseline pol Genotype in HIV-1 Fitness Evolution
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
• Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease following Different Protease Inhibitor Treatments
  Journal of Virology, 2003
• Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors
  AIDS, 2003
• Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
  New England Journal of Medicine, 2002
• Acute HIV infection: impact on the spread of HIV and transmission of drug resistance
  AIDS, 2001
• Secondary Mutations in the Protease Region of Human Immunodeficiency Virus and Virologic Failure in Drug‐Naive Patients Treated with Protease Inhibitor–Based Therapy
  The Journal of Infectious Diseases, 2001
• Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients
  AIDS, 1997
• Extensive polymorphisms observed in HIV–1 clade B protease gene using high–density oligonucleotide arrays
  Nature Medicine, 1996